These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38745837)

  • 1. Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma.
    Soong W; Chipps BE; Carr W; Trevor J; Patel A; Clarke N; Carstens DD; Ambrose CS
    J Asthma Allergy; 2024; 17():441-448. PubMed ID: 38745837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma.
    Soong W; Chipps BE; O'Quinn S; Trevor J; Carr WW; Belton L; Trudo F; Ambrose CS
    J Asthma Allergy; 2021; 14():713-725. PubMed ID: 34211280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic and maintenance systemic corticosteroid therapy among US subspecialist-treated patients with severe asthma.
    Moore WC; Panettieri RA; Trevor J; Ledford DK; Lugogo N; Soong W; Chipps BE; Carr W; Belton L; Gandhi H; Trudo F; Ambrose CS
    Ann Allergy Asthma Immunol; 2020 Sep; 125(3):294-303.e1. PubMed ID: 32304877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic use and outcomes among adults with severe asthma treated by US subspecialists.
    Panettieri RA; Ledford DK; Chipps BE; Soong W; Lugogo N; Carr W; Mohan A; Carstens D; Genofre E; Trudo F; Ambrose CS
    Ann Allergy Asthma Immunol; 2022 Oct; 129(4):467-474.e3. PubMed ID: 35728746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe asthma exacerbation rates are increased among female, Black, Hispanic, and younger adult patients: results from the US CHRONICLE study.
    Lugogo N; Judson E; Haight E; Trudo F; Chipps BE; Trevor J; Ambrose CS
    J Asthma; 2022 Dec; 59(12):2495-2508. PubMed ID: 35000529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE.
    Panettieri RA; Lugogo N; Moore WC; Chipps BE; Jepson B; Zhou W; Ambrose CS; Genofre E; Carstens DD
    Respir Med; 2023 Sep; 216():107285. PubMed ID: 37290579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the COVID-19 Pandemic on Incidence of Asthma Exacerbations and Hospitalizations in US Subspecialist-Treated Patients with Severe Asthma: Results from the CHRONICLE Study.
    Moore WC; Ledford DK; Carstens DD; Ambrose CS
    J Asthma Allergy; 2022; 15():1195-1203. PubMed ID: 36068863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results.
    Ambrose CS; Chipps BE; Moore WC; Soong W; Trevor J; Ledford DK; Carr WW; Lugogo N; Trudo F; Tran TN; Panettieri RA
    Pragmat Obs Res; 2020; 11():77-90. PubMed ID: 32765156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe asthma exacerbations in the United States:: Incidence, characteristics, predictors, and effects of biologic treatments.
    Trevor J; Lugogo N; Carr W; Moore WC; Soong W; Panettieri RA; Desai P; Trudo F; Ambrose CS
    Ann Allergy Asthma Immunol; 2021 Nov; 127(5):579-587.e1. PubMed ID: 34273485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study.
    Müllerová H; Cockle SM; Gunsoy NB; Nelsen LM; Albers FC
    J Asthma; 2021 Apr; 58(4):459-470. PubMed ID: 31874051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.
    Nelsen LM; Kimel M; Murray LT; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
    Respir Med; 2017 May; 126():32-38. PubMed ID: 28427547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient characteristics and eligibility for biologics in severe asthma: Results from the Greek cohort of the RECOGNISE "real world" study.
    Bakakos P; Tryfon S; Palamidas A; Mathioudakis N; Galanakis P
    Respir Med; 2023; 210():107170. PubMed ID: 36841360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of patient-reported asthma triggers predicts uncontrolled disease among specialist-treated patients with severe asthma.
    Chipps BE; Soong W; Panettieri RA; Carr W; Gandhi H; Zhou W; Cook B; Llanos JP; Ambrose CS
    Ann Allergy Asthma Immunol; 2023 Jun; 130(6):784-790.e5. PubMed ID: 36906262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment for Efficacy of Additional Breathing Exercises Over Improvement in Health Impairment Due to Asthma Assessed using St. George's Respiratory Questionnaire.
    Agarwal D; Gupta PP; Sood S
    Int J Yoga; 2017; 10(3):145-151. PubMed ID: 29422745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
    Harrison TW; Chanez P; Menzella F; Canonica GW; Louis R; Cosio BG; Lugogo NL; Mohan A; Burden A; McDermott L; Garcia Gil E; Zangrilli JG;
    Lancet Respir Med; 2021 Mar; 9(3):260-274. PubMed ID: 33357499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL-5 therapies for asthma.
    Farne HA; Wilson A; Milan S; Banchoff E; Yang F; Powell CV
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD010834. PubMed ID: 35838542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world severe asthma biologic administration and adherence differs by biologic: CHRONICLE study results.
    Ledford DK; Soong W; Carr W; Trevor J; Tan L; Carstens D; Ambrose CS
    Ann Allergy Asthma Immunol; 2023 Nov; 131(5):598-605.e3. PubMed ID: 37506846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary rehabilitation versus usual care for adults with asthma.
    Osadnik CR; Gleeson C; McDonald VM; Holland AE
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013485. PubMed ID: 35993916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.
    Nelsen LM; Vernon M; Ortega H; Cockle SM; Yancey SW; Brusselle G; Albers FC; Jones PW
    Respir Med; 2017 Jul; 128():42-49. PubMed ID: 28610668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.